BioRestorative Therapies (BRTX) Return on Sales [ROS] (2012 - 2026)
BioRestorative Therapies (BRTX) reported Return on Sales [ROS] of -14612.57% for Q1 2026, up 4617.56 percentage points from -19230.14% a year earlier and up 4904.26 percentage points from the prior quarter.
BioRestorative Therapies (BRTX) Return on Sales [ROS] (2012 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, BioRestorative Therapies' Return on Sales [ROS] came in at -3975.00%, down 841.12 percentage points year-over-year; for FY2025, it was -4350.05%, down 1468.46 percentage points from FY2024.
- Return on Sales [ROS] has a five-year change of -775.93 percentage points (FY2020 to FY2025).
- By year, Return on Sales [ROS] came in at -2881.59% in FY2024 (+7557.89 pp), -10439.49% in FY2023 (+5398.60 pp), -15838.08% in FY2022 (+41352.94 pp) and -57191.03% in FY2021 (-53616.90 pp).
- Five-year quarterly Return on Sales [ROS] spans a low of -126537.95% in Q4 2022 and a high of -979.02% in Q3 2024.
- Year over year, Return on Sales [ROS] gained in five of the last eight quarters, with an average year-over-year change of -2909.90 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was Q4 2023 (a gain of 109850.47 percentage points); the low point was Q4 2021 (a drop of 75159.08 percentage points).
- Per Business Quant data, the three quarters before Q1 2026 came in at -19516.84% (Q4 2025), -31432.30% (Q3 2025) and -1089.77% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | BioRestorative Therapies | 1.36 Mn | -17.06 Mn | 15,785.00 | -14,612.57% |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -14,612.57% |
| Dec 31, 2025 | -19,516.84% |
| Sep 30, 2025 | -31,432.30% |
| Jun 30, 2025 | -1,089.77% |
| Mar 31, 2025 | -19,230.14% |
| Dec 31, 2024 | -6,212.80% |
| Sep 30, 2024 | -979.02% |
| Jun 30, 2024 | -2,770.83% |
| Mar 31, 2024 | -11,740.72% |
| Dec 31, 2023 | -16,687.47% |
| Sep 30, 2023 | -10,112.19% |
| Jun 30, 2023 | -4,831.86% |
| Mar 31, 2023 | -18,463.57% |
| Dec 31, 2022 | -126,537.95% |
| Sep 30, 2022 | -15,895.52% |
| Jun 30, 2022 | -6,510.03% |
| Mar 31, 2022 | -31,586.21% |
| Dec 31, 2021 | -80,185.34% |
| Sep 30, 2021 | -46,108.59% |
| Jun 30, 2021 | -23,701.75% |
BioRestorative Therapies Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();